Condition

Complete Remission in Renal Cell Carcinoma (1)

Overall Status

Completed (1)

Sign in for free

Phase

Sponsor

Pfizer (1)

Collaborator

Intervention

sunitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Observational (1)

complete remission in renal cell carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CR With Sunitinib Treatment In mRCC Patients

Completed

Complete Remission in Renal Cell Carcinoma

sunitinib

Marseille, Cedex 5, France
+13 more

Feb 14, 2022